LC3 was found to be related to tumor growth and progression of triple negative breast cancer (22), and be associated with clinical prognosis of pancreatic cancer (23), hepatocellular carcinoma (24) and colorectal cancer (25). The gene discussed is MAP1LC3A; the disease is familial pancreatic carcinoma.